Literature DB >> 1234505

Effect of age, height, weight and sex on serum phenytoin concentration in epileptic patients.

G W Houghton, A Richens, M Leighton.   

Abstract

1 Steady-state serum phenytoin concentrations were measured in adult epileptic patients receiving a maintenance dose of phenytoin (300 mg daily). 2 Serum phenytoin concentration showed a positive correlation with age. 3 Serum phenytoin concentration showed a negative correlation with body weight and with height. Multiple correlation analysis indicated that body weight influenced the concentration to a much greater degree than height. 4 When corrected for body weight and height, the serum phenytoin concentrations in women were lower than those in men, although the difference was not statistically significant. 5 Although each of these factors contributes to the interindividual variation in serum phenytoin concentrations, the contribution of each is small. Other factors, such as genetic differences and the effect of saturation kinetics, are much more important in determining steady-state concentrations. Adjusting the dose according to the age, weight and height of a patient would achieve only a marginal improvement in therapy.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1234505      PMCID: PMC1402573          DOI: 10.1111/j.1365-2125.1975.tb01583.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  13 in total

1.  DIPHENYLHYDANTOIN AND PHENOBARBITAL. SERUM LEVELS IN CHILDREN.

Authors:  O SVENSMARK; F BUCHTHAL
Journal:  Am J Dis Child       Date:  1964-07

2.  Metabolism of drugs and carcinogens by human liver enzymes.

Authors:  R Kuntzman; L C Mark; L C Brand; B M Jacobson; W Levin; A H Conney
Journal:  J Pharmacol Exp Ther       Date:  1966-04       Impact factor: 4.030

Review 3.  Biochemical and genetic factors regulating dilantin metabolism in man.

Authors:  H Kutt
Journal:  Ann N Y Acad Sci       Date:  1971-07-06       Impact factor: 5.691

4.  Pharmacokinetic study of a patient with diphenylhydantoin toxicity.

Authors:  A J Atkinson; J M Shaw
Journal:  Clin Pharmacol Ther       Date:  1973 Jul-Aug       Impact factor: 6.875

5.  Diphenylhydantoin dosage.

Authors:  M J Eadie; J H Tyrer; W D Hooper
Journal:  Proc Aust Assoc Neurol       Date:  1973

6.  Influence of ethylphenacemide on serum levels of other anti-epileptic drugs.

Authors:  J W Huisman; M W van Heycop ten Ham; C H van Zijl
Journal:  Epilepsia       Date:  1970-06       Impact factor: 5.864

7.  Value of blood phenytoin estimation in management of childhood epilepsy.

Authors:  K P Dawson; A Jamieson
Journal:  Arch Dis Child       Date:  1971-06       Impact factor: 3.791

8.  Variation in response to anticonvulsants in a group of epileptic patients.

Authors:  R D Travers; E H Reynolds; B B Gallagher
Journal:  Arch Neurol       Date:  1972-07

9.  The distribution of plasma phenytoin levels in epileptic patients.

Authors:  P T Lascelles; R S Kocen; E H Reynolds
Journal:  J Neurol Neurosurg Psychiatry       Date:  1970-08       Impact factor: 10.154

10.  Phenytoin intoxication induced by sulthiame in epileptic patients.

Authors:  G W Houghton; A Richens
Journal:  J Neurol Neurosurg Psychiatry       Date:  1974-03       Impact factor: 10.154

View more
  21 in total

1.  The 'apparent clearance' of free phenytoin in elderly vs. younger adults.

Authors:  Daniel F B Wright; Evan J Begg
Journal:  Br J Clin Pharmacol       Date:  2010-07       Impact factor: 4.335

2.  Interaction between phenytoin and imipramine.

Authors:  E Perucca; A Richens
Journal:  Br J Clin Pharmacol       Date:  1977-08       Impact factor: 4.335

3.  Age as a factor affecting lithium therapy.

Authors:  D S Hewick; P Newbury; S Hopwood; G Naylor; J Moody
Journal:  Br J Clin Pharmacol       Date:  1977-04       Impact factor: 4.335

Review 4.  Differential kinetics of phenytoin in elderly patients.

Authors:  K A Bachmann; R J Belloto
Journal:  Drugs Aging       Date:  1999-09       Impact factor: 3.923

Review 5.  Drug use in the elderly: a review of problems and special considerations.

Authors:  R E Vestal
Journal:  Drugs       Date:  1978-10       Impact factor: 9.546

Review 6.  Influence of sex on drug kinetics in man.

Authors:  J F Giudicelli; J P Tillement
Journal:  Clin Pharmacokinet       Date:  1977 May-Jun       Impact factor: 6.447

7.  Effects of subjects' sex, and intake of tobacco, alcohol and oral contraceptives on plasma phenytoin levels.

Authors:  E A De Leacy; C D McLeay; M J Eadie; J H Tyrer
Journal:  Br J Clin Pharmacol       Date:  1979-07       Impact factor: 4.335

8.  Disposition of antipyrine and phenytoin correlated with age and liver volume in man.

Authors:  B Bach; J M Hansen; J P Kampmann; S N Rasmussen; L Skovsted
Journal:  Clin Pharmacokinet       Date:  1981 Sep-Oct       Impact factor: 6.447

Review 9.  Pharmacokinetics in the elderly.

Authors:  J Crooks; K O'Malley; I H Stevenson
Journal:  Clin Pharmacokinet       Date:  1976       Impact factor: 6.447

10.  Steady-state pharmacokinetics of phenytoin from routinely collected patient data.

Authors:  T H Grasela; L B Sheiner; B Rambeck; H E Boenigk; A Dunlop; P W Mullen; J Wadsworth; A Richens; T Ishizaki; K Chiba
Journal:  Clin Pharmacokinet       Date:  1983 Jul-Aug       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.